Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study was to examine the effect of six- to eight-week treatment with
MicardisPlus® on blood pressure and the effect of patient self-monitoring on blood pressure
control. In addition, the post-marketing surveillance study offered the possibility to obtain
information about the influence on different laboratory parameters during treatment with
MicardisPlus® from an unselected patient group under office conditions
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Hydrochlorothiazide Telmisartan Telmisartan, hydrochlorothiazide drug combination